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ABSTRACT
Background. Diabetes mellitus is a pandemic disease. 
Type 2 diabetes (T2DM) is the most common type. 
Diabetic retinopathy (DR) and diabetic kidney disease 
(DKD) are disabling chronic complications. The relation 
between both is not yet well-established in T2DM. 
Egypt is considered one of the top ten countries re-
garding the prevalence of diabetes that makes diabetes 
and its complications a major health problem. This 
encouraged us to conduct this research.
Materials and methods. The study included 79 patients 
with T2DM divided into two groups according to the 
presence of retinopathy. Both groups were subdivided 
according to urinary albumin to creatinine ratio (UACR) 
into normoalbuminuric and albuminuric subgroups. 
Retinopathy group was further subdivided according 
to severity of retinopathy into mild, moderate and 
severe non-proliferative DR (NPDR). Statistical analysis 
was done and relation between the severity of retino-
pathy and UACR was studied.
Results. Patients with retinopathy had significantly 
higher diabetes duration and UACR than non retin-
opathy group. Also in subgroups of normoalbuminuria 
and albuminuria, retinopathy group was significantly 
higher regarding the same parameters. On subdividing 
the retinopathy group according to severity, severe 
NPDR group had significantly higher UACR. The severity 
of DR was significantly positively correlated with UACR.
Conclusions. The present study identified a significantly 
positive correlation between early stages of DR and 
UACR in patients with T2DM in Egypt. Not all cases of 
DR had DKD especially in early stages and also not all 
cases of DKD are associated with the presence of DR 
in T2DM. (Clin Diabetol 2019; 8, 3: 154–160)
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Introduction
Diabetes mellitus (DM) is considered a global 
health problem due to its high prevalence and the high 
incidence of its chronic complications. It is considered 
the leading cause of blindness, end stage renal disease 
(ESRD) and lower limb amputation worldwide [1]. 
According to recent statistics, the Middle East is con-
sidered an emerging hot spot in developing diabetes. 
Egypt is ranked as one of the top ten countries in the 
prevalence of diabetes (16.7% of the adult Egyptian 
population) [2].
Diabetic retinopathy (DR) is one of the major 
chronic microvascular complications of diabetes. 
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Worldwide, the prevalence of DR among people with 
diabetes is about one third [3]. The duration of diabetes 
and the level of glycemic control are strongly related to 
DR. Moreover, chronic hyperglycemia, diabetic kidney 
disease (DKD), hypertension and dyslipidemia increase 
the risk of DR [4].
Diabetic kidney disease is another disabling mi-
crovascular complication of diabetes. The Diagnosis 
of DKD is based on the presence of albuminuria and 
measurement of estimated glomerular filtration rate 
(eGFR). The pathogenesis of microvascular complica-
tions is multifactorial and difficult to understand [5].
The relation between DR and DKD is well-estab-
lished in type 1 diabetes (T1DM). In type 2 diabetes 
(T2DM), this association is less clear especially in early 
stages [6]. The prevalence of DR may reach 63% in pa-
tients with T2DM with proteinuria [7]. The presence of 
DKD in the absence of DR should suspect a nondiabetic 
renal disease [8]. This study was conducted to study the 
relation between early stages of DR and early stages of 
DKD in T2DM in Egypt.
Materials and methods
This cross sectional study was conducted on 79 
patients with T2DM recruited from the diabetes out-
patient clinic of Alexandria Main University Hospital, 
Faculty of Medicine, Alexandria University, Alexandria, 
Egypt. Exclusion criteria were: urinary tract infection, 
estimated glomerular filtration rate (eGFR) less than 
60 ml/min, patients with severely increased urinary 
albumin excretion (UACR > 300 mg/g), pregnancy 
and lactation. 
This work was done in accordance with the Ethi-
cal Principles for Medical Research Involving Human 
Subjects outlined in the Helsinki Declaration in 1975 
(revised in 2008). An approval was obtained from ethics 
committee of Faculty of Medicine, Alexandria University. 
Each participant had signed a written informed consent 
before participating in the study.
Patients were subjected to full history taking in-
cluding history of smoking, hypertension, dislipidemia 
and diabetes duration. Complete physical examination 
was performed including blood pressure measurement, 
weight, height, body mass index (BMI) that was calcu-
lated as body weight [kg] divided by body height squared 
[m²] and waist circumference (WC) that was measured 
from the midpoint between highest point of the iliac 
crest and lowest point of the costal margin at the end 
of normal expiration according to the WHO recom-
mendation. Screening for diabetic sensorimotor poly-
neuropathy was done using: The 10-g monofilament 
using Semmes-Weinstein 5.07 (10 g) monofilament [9], 
vibration sense: using a neurothesiometer, the methods 
were based on the International Working Group on the 
Diabetic Foot of the IDF [10] and the ankle reflex was 
also examined. 
Fundus examination was done in ophthalmology 
outpatient clinic of Alexandria Main University Hospital 
using slit lamp biomicroscope plus fundus lens by the 
same efficient ophthalmology consultant for all cases. 
Eight ml of blood were drawn from the anticubital 
vein for each patient and a spot of urine sample was 
taken for complete urine analysis and measurement of 
urinary albumin to creatinine ratio (UACR). Albuminuria 
was confirmed by being positive in two of three speci-
mens of UACR collected within a 3 to 6-month period. 
Each blood sample was divided between K2-EDTA va-
cutainer tubes for glycated heamoglobin (HbA1c) and a 
clot activator serum vacutainer tube for chemistry tests. 
Routine laboratory tests were done as follows: HbA1c, 
fasting plasma glucose, blood urea, serum creatinine 
and measurement of estimated GFR using The Chronic 
Kidney Disease Epidemiology Collaboration (CKD-EPI) 
equation [11], total serum cholesterol, high density 
lipoprotein cholesterol (HDL-C), low density lipoprotein 
cholesterol (LDL-C) and serum triglycerides.
Cases were divided according to the presence of 
diabetic retinopathy into two groups (Table 1): 49 pa-
tients without retinopathy and 30 patients with retin-
opathy (all had nonproliferative diabetic retinopathy 
(NPDR) divided according to severity into mild (n = 12), 
moderate (n = 13) and severe NPDR (n = 5) (Table 2). 
Each group was further subdivided into two 
subgroups according to urinary albumin to creatinine 
ratio (UACR) into normoalbuminuric group (UACR 
< 30 mg/g) and albuminuric group (with moderately 
increased urinary albumin excretion UACR 30–300 
mg/g [formerly called microalbuminuria]). Within the 
group without retinopathy, 26 patients had normoal-
buminuria and 23 patients had albuminuria while in 
the retinopathy group, 13 patients had normoalbu-
minuria and 17 patients had albuminuria. The base 
line characteristics of each subgroup are presented in 
Table 3. Correlations between severity of DR and other 
parameters were measured (Table 4). 
Statistical analysis of the data was done using IBM 
SPSS software package version 20.0. (Armonk, NY: IBM 
Corp). Qualitative data were described using number 
and percent. The Kolmogorov-Smirnov test was used to 
verify the normality of distribution. Quantitative data 
were described using range (minimum and maximum), 
mean, standard deviation and median. Significance of 
the obtained results was judged at the 5% level. 
The used tests were: 
1. Chi-square test: for categorical variables, to 
compare between different groups.
Clinical Diabetology 2019, Vol. 8, No. 3
156
2. Fisher’s Exact or Monte Carlo correction: cor-
rection for chi-square when more than 20% of 
the cells have expected count less than 5.
3. Student t test: for normally distributed quantita-
tive variables, to compare between two groups.
4. F-test (ANOVA): for normally distributed quanti-
tative variables, to compare between more than 
two groups, and post hoc test (LSD) for pairwise 
comparisons. 
5. Kruskal-Wallis test: for abnormally distributed 
quantitative variables, to compare between 
more than two studied groups and post hoc 
(Dunn’s multiple comparisons test) for pairwise 
comparisons.
6. Spearman correlation coefficient was used to 
identify the correlation between the severity of 
retinopathy and other parameters.
Results
Among the 79 patients with diabetes included in 
this study, 49 had no retinopathy and 30 had diabetic 
retinopathy (all of them had nonprolifirative diabetic 
retinopathy (NPDR) with different stages). The two 
groups were comparable regarding different param-
eters with no statistically significant difference except 
for few parameters (Table 1). 
Regarding duration of diabetes it was highly 
statistically significantly increased in the retinopathy 
group than in the no retinopathy group. Regarding 
peripheral neuropathy assessment (monofilament, 
ankle reflex and vibration sense (using vibration percep-
tion threshold by neurothesiometer)), they were highly 
significantly different between the 2 groups. Also UACR 
was highly significantly increased in the retinopathy 
group than in the group without retinopathy.
Table 1. Comparison between the two studied groups according to different parameters
No retinopathy (n = 49) Retinopathy (n = 30) Test of sig. P
Gender
Male 32 (65.3%) 17 (56.7%) c2 = 0.590 0.443
Female 17 (34.7%) 13 (43.3%)
Age (years)
Median (min.–max.) 51 (30–65) 52.5 (38–68) t = 0.902 0.370
Mean ± SD 50.2 ± 8.2 51.9 ± 8
Diabetes duration (years)
Median (min.–max.) 3 (0.5–23) 8.5 (1–20) U = 342.5* < 0.001*
Mean ± SD 4.3 ± 4 8.9 ± 5.6
BMI [kg/m2]
Median (min.–max.) 30 (20–45) 28.8 (21.5–42) t = 1.230 0.223
Mean ± SD 30.7 ± 6.1 29.1 ± 4.7
Waist circumference [cm]
Median (min.–max.) 100 (71–140) 103 (82–125) t = 0.756 0.452
Mean ± SD 100 ± 11.9 102 ± 10.9
Monofilament
Absent 1 (2%) 4 (13.3%) c2 = 17.417* < 0.001*
Normal 46 (93.9%) 16 (53.3%)
Decreased 2 (4.1%) 10 (33.3%)
Vibration (VPT)
Median (min.–max.) 15 (6–50) 33.5 (9–100) U = 318.5* < 0.001*
Mean ± SD 16.8 ± 9.6 34.1 ± 21.2
Ankle reflex
Absent 15 (30.6%) 18 (60%) c2 = 9.709* 0.008*
Normal 29 (59.2%) 7 (23.3%)
Reinforcement 5 (10.2%) 5 (16.7%)
FPG [mg/dl]
Median (min.–max.) 150 (80–390) 156 (102–336) U = 722.0 0.895
Mean ± SD 164.3 ± 58.9 172.6 ± 66.4
HbA1c (%)
Median (min.–max.) 8.1 (5.6–14.5) 9 (6–13.3) t = 1.300 0.197
Mean ± SD 8.6 ± 1.8 9.2 ± 1.8
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Subdividing each group according to UACR into 
normoalbuminuric group and albuminuric group, 
the duration of diabetes was significantly higher in 
both retinopathy subgroups than in both subgroups 
without retinopathy but not between the albuminuric 
and normoalbuminuric subgroups within each group 
(Table 3). Regarding UACR it was significantly higher 
in the albuminuric group with retinopathy than the 
3 other subgroups while there was no statistically sig-
nificant difference between the 2 normoalbuminuric 
Table 1 (cd). Comparison between the two studied groups according to different parameters
No retinopathy (n = 49) Retinopathy (n = 30) Test of sig. P
Albumin [g/dl]
Median (min.–max.) 3.7 (2.8–4.8) 3.7 (3–4.9) t = 0.172 0.864
Mean ± SD 3.7 ± 0.4 3.7 ± 0.4
Creatinine [mg/dl]
Median (min.–max.) 0.8 (0.5–1.2) 0.8 (0.5–1.2) t = 0.688 0.494
Mean ± SD 0.8 ± 0.1 0.8 ± 0.2
eGFR [EPI] ml/min
Median (min.–max.) 96 (61–135) 97.8 (61–125.8) t = 0.178 0.859
Mean ± SD 94.5 ± 17.4 95.2 ± 16.6
Cholesterol [mg/dl]
Median (min.–max.) 200 (113–272) 187 (106–285) t = 1.115 0.268
Mean ± SD 194 ± 39 183.6 ± 42.1
Triglycerides [mg/dl]
Median (min.–max.) 162 (46–300) 166.5 (43–336) t = 0.232 0.818
Mean ± SD 159.5 ± 53.3 163.2 ± 76.9
HDL-C [mg/dl]
Median (min.–max.) 45 (24–74) 44.5 (25–55) t = 1.051 0.297
Mean ± SD 46.5 ± 10 44.2 ± 8.5
LDL-C [mg/dl]
Median (min.–max.) 110 (51.8–188) 108 (59–201) t = 0.414 0.680
Mean ± SD 113 ± 36.2 109.7 ± 32.8
UACR [mg/g]
Median (min.–max.) 20 (3.4–91) 91.3 (6–298) U = 362.5* < 0.001*
Mean ± SD 31.5 ± 25.9 96.6 ± 84.4
χ2 — Chi-square test; t — Student t-test; U — Mann-Whitney test; p — p value for comparing between the studied groups; *statistically significant at p ≤ 0.05
Table 2. Relation between severity retinopathy and different parameters (n = 30)
Severity Retinopathy Test of sig. p
Mild NPDR 
(n = 12)
Moderate NPDR 
(n = 13)
Severe NPDR 
(n = 5)
Diabetes duration (years)
Median (min.–max.) 6 (1–12) 7 (2–20) 10 (3–20) H = 2.167 0.338
Mean ± SD 6.7 ± 3.7 9.9 ± 6.6 11.2 ± 6.1
eGFR EPI [ml/min]
Median (min.–max.) 93 (63.5–123) 97 (61–125.8) 102 (72–110) F = 0.222 0.802
Mean ± SD 92.7 ± 17.3 96.6 ± 17.6 97.5 ± 15
UACR [mg/g]
Median (min.–max.) 32.1 (6–134) 29.9 (27.3–163.5) 270 (179.5–298) H = 14.155* 0.001*
Mean ± SD 55.7 ± 47.3 79.2 ± 59.6 240ab ± 55.9
F — F for ANOVA test; H — H for Kruskal-Wallis test. Pairwise comparison bet. each 2 groups was done using post hoc test (Dunn’s for multiple compari-
sons test); p — p value for comparing between different categories; *statistically significant at p ≤ 0.05; a — significant with mild NPDR; b — significant 
with moderate NPDR; UACR — urinary albumin to creatinine ratio; NPDR — non-proliferative diabetic retinopathy
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subgroups regarding UACR although the mean value 
of UACR was higher in the normoalbuminuric group 
with retinopathy.
Regarding severity of retinopathy (Table 2) the 
three subgroups were comparable regarding different 
parameters without statistically significant difference 
except for UACR that was highly significantly higher in 
cases of severe NPDR.
On performing correlation between severity of 
retinopathy and different parameters, it was highly 
significantly positively correlated with UACR with no 
significant correlation with other parameters (Table 4, 
Figure 1).
Table 3. Comparison between the four studied subgroups according to different parameters
No retinopathy (n = 49) Retinopathy (n = 30) Test of sig. p
Normoalbuminuria 
(n = 26)
Albuminuria  
(n = 23)
Normoalbuminuria 
(n = 13)
Albuminuria  
(n = 17)
Diabetes duration
Median (min.–max.) 4 (0.5–23) 2 (0.5–10) 7 (1–20) 10 (1.5–20) H = 17.646* 0.001*
Mean ± SD 5.2a ± 4.8 3.3a ± 2.5 8.4b ± 5.2 9.2b ± 6.1
Monofilament
Absent 1 (3.8%) 0 (0%) 2 (15.4%) 2 (11.8%) c2 = 20.217* < 0.001*
N 25 (96.2%) 21 (91.3%) 8 (61.5%) 8 (47.1%)
Dec 0 (0%) 2 (8.7%) 3 (23.1%) 7 (41.2%)
Vibration (VPT)
Median (min.–max.) 12 (6–40) 16 (6–50) 30 (9–90) 34 (10–100) H = 20.215* < 0.001*
Mean ± SD 14.8c ± 8.2 19ac ± 10.7 31.8ab ± 20.7 35.9b ± 22.1
Ankle reflex
Absent 10 (38.5%) 5 (21.7%) 7 (53.8%) 11 (64.7%) c2 = 13.564* 0.024*
Normal 15 (57.7%) 14 (60.9%) 3 (23.1%) 4 (23.5%)
Reinforcement 1 (3.8%) 4 (17.4%) 3 (23.1%) 2 (11.8%)
FPG [mg/dl]
Median (min.–max.) 150 (89–306) 150 (80–390) 130 (102 –336) 168 (102 –300) H = 0.725 0.867
Mean ± SD 162.4b ± 56.1 166.5b ± 63.1 166.2b ± 71.9 177.6b ± 63.7
HbA1c (%)
Median (min.–max.) 7.8 (5.6–12.4) 8.5 (6.5 – 14.5) 9 (7.1–13.3) 9 (6–12.2) F = 1.254 0.296
Mean ± SD 8.3 ± 1.7 9 ± 2 9.2 ± 1.6 9.2 ± 1.9
Creatinine [mg/dl]
Median (min.–max.) 0.8 (0.6–1.1) 0.9 (0.5–1.2) 0.8 (0.5–1) 0.9 (0.5–1.2) F = 0.850 0.471
Mean ± SD 0.8 ± 0.1 0.9 ± 0.2 0.8 ± 0.2 0.9 ± 0.2
eGFR EPI [ml/min]
Median (min.–max.) 96 (61–123) 98 (61–135) 97 (63.5125.8) 98 (61–123) F = 0.107 0.956
Mean ± SD 93.6 ± 13.8 95.4 ± 21.1 96.6 ± 15.8 94.1 ± 17.7
UACR [mg/g]
Median (min.–max.) 9.3 (3.4–20.5) 52 (30.4–91) 27.3 (6 – 29.9) 149 (39.5–298) H = 67.948* < 0.001*
Mean ± SD 10.7c ± 5.8 55.1a ± 18.3 22.5c ± 8.2 153.3b ± 70.5
χ2 — Chi-square test; F — F for ANOVA test; H — H for Kruskal Wallis test; p — p value for comparing between the studied groups; *statistically significant 
at p ≤ 0.05. Means with common letters are not significant (i.e. means with different letters are significant)
Table 4. Correlation between severity of retinopathy and 
different parameters (n = 30)
Severity retinopathy
rs p
UACR 0.642* < 0.001*
eGFR EPI 0.137 0.472
Diabetes duration 0.273 0.144
Systolic blood pressure [mm Hg] 0.097 0.612
Diastolic blood pressure [mm Hg] –0.034 0.858
rs — Spearman coefficient; *statistically significant at p ≤ 0.05; UACR — 
urinary albumin to creatinine ratio; eGFR — estimated glomerular filtra-
tion rate
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Discussion
Although the association between diabetic retin-
opathy and DKD is well established in T1DM, it is 
less evident in T2DM especially in early cases of DKD 
with moderately increased UACR. To the best of our 
knowledge, no previous studies clearly discussed the 
relation between early stages of diabetic retinopathy 
and early stages of DKD in T2DM in Egypt. That’s why 
we conducted the present study.
In the present study, the patients with retinopathy 
had significantly higher UACR, significantly longer 
diabetes duration and significantly higher prevalence 
of peripheral neuropathy. Otherwise, groups and sub-
groups were comparable regarding other parameters.
Regarding the severity of DR, severe NPDR cases 
had significantly higher UACR than the other 2 groups. 
The severity of retinopathy was highly significantly 
positively correlated with UACR. 
Sanyal et al. [12] studied the association between 
retinopathy and nephropathy in diabetic patients 
with advanced renal disease. They concluded that 
retinopathy without nephropathy is common while 
nephropathy without retinopathy is rare. However, their 
patients had had advanced renal disease (ESRD) and 
this explains the discordance between their results and 
ours as we studied patients with diabetes with early 
stages of DKD and DR.
A meta-analysis involving 2012 patients from 26 
studies found that DR is useful in screening for or diag-
nosing DKD in patients with T2DM and renal disease, 
and they recognized proliferative DR as a highly specific 
indicator for DN [13]. The present study had similar re-
sults but regarding early stages of both complications.
In agreement with the results of the present 
study, Kotlarsky et al. [14] concluded that the degree 
of renal impairment is proportional to the degree of 
eye damage. In addition, they statistically proved the 
chronological relation between retinopathy and DKD; 
that the renal injury precedes the retinopathy.
Romero-Aroca et al. [15] studied the relationship 
between DR and DKD in T2DM and concluded that 
both UACR and eGFR are important risk factors of DR, 
although UACR has a better association. The present 
study revealed similar results regarding the relation 
between DR and UACR but not regarding eGFR, this 
may be due to the early stages of the disease included 
in the present study.
Zhang et al. [16] studied the relationship between 
DR and the DKD progression in patients with T2DM. They 
concluded that in patients with T2DM and DKD, DR may 
predict the renal prognosis. They found a significant asso-
ciation between the severity of glomerular lesions and DR.
Although the pathogenesis of all microvascular 
complications is similar (polyol pathway, protein kinase 
C pathway and advanced glycation end products) 
[17], this difference in the time of the beginning of 
each complication may be a result of genetic factors 
determining the susceptibility to DR irrespective to 
DKD. Many studies reported specific genes associated 
with or protective against DR [18–21]. Further studies 
are needed to prove the association between DR and 
DKD in T2DM with the identification of chronological 
sequence which occurs first.
Conclusions
The present study revealed significant relation be-
tween the severity of DR and the degree of albuminuria 
in early stages of DKD in cases with T2DM. Further 
studies are needed to confirm this relation and to reveal 
the chronological sequence of diabetic microvascular 
complications in T2DM.
Not all cases of DR have DKD especially in early 
stages and also not all cases of DKD are associated 
with the presence of DR in T2DM. Genetic predisposi-
tion may be present.
The study also concluded that patients with DR 
have significantly longer diabetes duration than pa-
tients without DR.
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Figure 1. Correlation between severity of retinopathy and 
UACR (n = 30). Severity of retinopathy: 1 — mild NPDR; 2 — 
moderate NPDR; 3 — severe NPDR. UACR — urinary albumin to 
creatinine ratio; NPDR — non-proliferative diabetic retinopathy
Clinical Diabetology 2019, Vol. 8, No. 3
160
REFERENCES 
1. American Diabetes Association. Standards of medical care in 
diabetes 2019. Diabetes Care. 2019; 42(Suppl 1): S1–S2, doi: doi.
org/10.2337/dc19-Sint01.
2. Khalil SH, Megallaa MH, Rohoma KH, et al. Prevalence of type 2 
diabetes mellitus in a sample of the adult population of Alexan-
dria, Egypt. Diabetes research and clinical practice 2018; 144: 
63–73, doi:10.1016/j.diabres.2018.07.025.
3. Yau JWY, Rogers SL, Kawasaki R, et al. Meta-Analysis for Eye Dis-
ease (META-EYE) Study Group. Global prevalence and major risk 
factors of diabetic retinopathy. Diabetes Care. 2012; 35(3): 556–
–564, doi: 10.2337/dc11-1909, indexed in Pubmed: 22301125.
4. Chew EY, Davis MD, Danis RP, et al. Action to Control Cardiovas-
cular Risk in Diabetes Eye Study Research Group. The effects of 
medical management on the progression of diabetic retinopathy 
in persons with type 2 diabetes: the Action to Control Cardio-
vascular Risk in Diabetes (ACCORD) Eye Study. Ophthalmology. 
2014; 121(12): 2443–2451, doi: 10.1016/j.ophtha.2014.07.019, 
indexed in Pubmed: 25172198.
5. American Diabetes Association. 11. Microvascular Complications 
and Foot Care: . Diabetes Care. 2019; 42(Suppl 1): S124–S138, 
doi: 10.2337/dc19-S011, indexed in Pubmed: 30559237.
6. Romero-Aroca P, Mendez-Marin I, Baget-Bernaldiz M, et al. Review 
of the Relationship between Renal and Retinal Microangiopathy 
in Diabetes Mellitus Patients. Current Diabetes Reviews. 2010; 
6(2): 88–101, doi: 10.2174/157339910790909387.
7. Collins AJ, Foley RN, Gilbertson DT, et al. United States Renal 
Data System public health surveillance of chronic kidney disease 
and end-stage renal disease. Kidney Int Suppl (2011). 2015; 5(1): 
2–7, doi: 10.1038/kisup.2015.2, indexed in Pubmed: 26097778.
8. Kanauchi M, Kawano T, Uyama H, et al. Discordance between reti-
nopathy and nephropathy in type 2 diabetes. Nephron. 1998; 80(2): 
171–174, doi: 10.1159/000045162, indexed in Pubmed: 9736815.
9. Pham H, Armstrong DG, Harvey C, et al. Screening techniques 
to identify people at high risk for diabetic foot ulceration: a pro-
spective multicenter trial. Diabetes Care. 2000; 23(5): 606–611, 
indexed in Pubmed: 10834417.
10. Apelqvist J, Bakker K, van Houtum WH, et al. International 
Working Group on the Diabetic Foot (IWGDF) Editorial Board. 
Practical guidelines on the management and prevention of the 
diabetic foot: based upon the International Consensus on the 
Diabetic Foot (2007) Prepared by the International Working Group 
on the Diabetic Foot. Diabetes Metab Res Rev. 2008; 24 Suppl 1: 
S181–S187, doi: 10.1002/dmrr.848, indexed in Pubmed: 
18442189.
11. Stevens LA, Schmid CH, Zhang YL, et al. Development and vali-
dation of GFR-estimating equations using diabetes, transplant 
and weight. Nephrol Dial Transplant. 2010; 25(2): 449–457, doi: 
10.1093/ndt/gfp510, indexed in Pubmed: 19793928.
12. Sanyal D, Chatterjee S. Advanced Diabetic Nephropathy with 
„Clean” Eyes: An Extreme Phenotype. Indian J Endocrinol Metab. 
2018; 22(2): 274–276, doi: 10.4103/ijem.IJEM_590_17, indexed 
in Pubmed: 29911044.
13. He F, Xia X, Wu XF, et al. Diabetic retinopathy in predicting diabetic 
nephropathy in patients with type 2 diabetes and renal disease: 
a meta-analysis. Diabetologia. 2013; 56(3): 457–466, doi: 10.1007/ 
/s00125-012-2796-6, indexed in Pubmed: 23232641.
14. Kotlarsky P, Bolotin A, Dorfman K, et al. Link between retinopathy 
and nephropathy caused by complications of diabetes mellitus 
type 2. Int Ophthalmol. 2015; 35(1): 59–66, doi: 10.1007/s10792-
014-0018-6, indexed in Pubmed: 25391917.
15. Romero-Aroca P, Baget-Bernaldiz M, Navarro-Gil R, et al. Glo-
merular Filtration Rate and/or Ratio of Urine Albumin to Creati-
nine as Markers for Diabetic Retinopathy: A Ten-Year Follow-Up 
Study. Journal of Diabetes Research. 2018; 2018: 1–9, doi: 
10.1155/2018/5637130.
16. Zhang J, Wang Y, Li Li, et al. Diabetic retinopathy may predict the 
renal outcomes of patients with diabetic nephropathy. Ren Fail. 
2018; 40(1): 243–251, doi: 10.1080/0886022X.2018.1456453, 
indexed in Pubmed: 29633887.
17. Brownlee M. Biochemistry and molecular cell biology of 
diabetic complications. Nature. 2001; 414(6865): 813–820, doi: 
10.1038/414813a, indexed in Pubmed: 11742414.
18. Hu QR, Huang LZ, Chen XL, et al. Genetic analysis and clinical 
features of X-linked retinoschisis in Chinese patients. Sci Rep. 
2017; 7: 44060, doi: 10.1038/srep44060, indexed in Pubmed: 
28272453.
19. Abhary S, Hewitt AW, Burdon KP, et al. A systematic meta-analysis 
of genetic association studies for diabetic retinopathy. Diabetes. 
2009; 58(9): 2137–2147, doi: 10.2337/db09-0059, indexed in 
Pubmed: 19587357.
20. Uthra S, Raman R, Mukesh BN, et al. Diabetic retinopathy: Vali-
dation study of ALR2, RAGE, iNOS and TNFB gene variants in 
a south Indian cohort. Ophthalmic Genet. 2010; 31(4): 244–251, 
doi: 10.3109/13816810.2010.523037, indexed in Pubmed: 
21067489.
21. Cilenšek I, Mankoč S, Petrovič MG, et al. GSTT1 null genotype is 
a risk factor for diabetic retinopathy in Caucasians with type 2 
diabetes, whereas GSTM1 null genotype might confer protec-
tion against retinopathy. Dis Markers. 2012; 32(2): 93–99, doi: 
10.3233/DMA-2011-0863, indexed in Pubmed: 22377702.
